灰心丧气
发表于 2025-3-28 17:05:20
http://reply.papertrans.cn/59/5853/585298/585298_41.png
tendinitis
发表于 2025-3-28 21:30:48
H. Theml,H. W. L. Ziegler-Heitbrock Our goal is to provide a ready-to-use, “hands-on” interface that does not need protracted explanation to the user, yet provides possibilities for expression. Therefore, our interface exploits the three-dimensional topology of physical sand, which is distributed over a tabletop surface. We discovere
挣扎
发表于 2025-3-29 00:41:22
K. P. Hellriegeley offer just a single channel of information. In order to support these groups with mixed interests, a more complex presentation method needs to be used. The method proposed in this paper combines a large stationary presentation system with several Personal Digital Assistants (PDAs), one for each u
exorbitant
发表于 2025-3-29 06:09:18
http://reply.papertrans.cn/59/5853/585298/585298_44.png
Jacket
发表于 2025-3-29 09:34:19
http://reply.papertrans.cn/59/5853/585298/585298_45.png
ANIM
发表于 2025-3-29 14:21:34
http://reply.papertrans.cn/59/5853/585298/585298_46.png
Pantry
发表于 2025-3-29 18:45:46
http://reply.papertrans.cn/59/5853/585298/585298_47.png
接合
发表于 2025-3-29 22:52:27
Allogeneic Bone Marrow Transplantation in Leukemia,achieved in a majority and long-term survival in a minority of patients with severely myelotoxic treatment regimens . In contrast to acute leukemia, the prognosis of chronic myeloid leukemia has changed little with modern chemotherapy .
deriver
发表于 2025-3-30 03:10:00
Cytogenetics in Leukemia: Implications for Pathogenesis and Prognosis,ning of therapeutic strategies. In this article we will concentrate on what cytogenetics can tell us about the pathogenesis of leukemias, leukemogenesis, and the role of chromosomes in the prognosis of patients with leukemic conditions. Diagnostic chromosomal findings will be described only briefly in the context of the aforementioned topics.
亚当心理阴影
发表于 2025-3-30 07:00:36
Current Status of ALL/AUL Therapy in Adults,n childhood ALL, e.g., intensification of induction therapy, prophylaxis against central nervous system (CNS) leukemia and prolongation of maintenance therapy, are now also showing benefit in adult ALL therapy.